Evidence map›Paper›PMID 30840835›Full record

ArticleAnnals of the American Thoracic Society2019

Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis.

Ranjani Somayaji, Renee Russell, Jonathan D Cogen, Cristopher H Goss, Sarah E Nick, Milene T Saavedra, Jennifer L Taylor-Cousar, Jerry A Nick, Dave P Nichols

Open access · greenAbstract readComparative Study
In one paragraph

Article in Annals of the American Thoracic Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Drugs, Drugs, Drugs: Current Treatment Paradigms in Cystic Fibrosis Airway Infections.Journal of the Pediatric Infectious Diseases Society · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis.American journal of respiratory and critical care medicine · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Ranjani Somayaji1 Department of Medicine and.
Renee Russell3 Department of Biostatistics.
Jonathan D Cogen4 Department of Pediatrics, and.
Cristopher H Goss4 Department of Pediatrics, and.
Sarah E Nick6 Department of Medicine, National Jewish Health, Denver, Colorado.
Milene T Saavedra6 Department of Medicine, National Jewish Health, Denver, Colorado.
Jennifer L Taylor-Cousar6 Department of Medicine, National Jewish Health, Denver, Colorado.
Jerry A Nick6 Department of Medicine, National Jewish Health, Denver, Colorado.
Dave P Nichols4 Department of Pediatrics, and.
Pediatrics and Genetics · USNational Jewish Health · USUniversity of Colorado Denver · USCancer Research And Biostatistics · USUniversity of Calgary · CA

Funding

Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss · 2010 to 2026
$21.4M
Biostatistics, Epidemiologic & Bioinformatic Training in Environmental HealthT32ES015459 · NIEHS · UNIVERSITY OF WASHINGTON · PI June T. Spector · 2009 to 2026
$10.6M
A prospective trial of oral azithromycin when added to inhaled tobramycin in CFR01HL124053 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI NICHOLS, DAVID PAUL · 2015 to 2019
$2.8M
NHLBI NIH HHS R01 HL124053NIDDK NIH HHS P30 DK089507NIEHS NIH HHS T32 ES015459
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, InhalationAdministration, IntravenousAdultAnti-Bacterial AgentsAzithromycinColistinCystic FibrosisDisease ProgressionFemaleForced Expiratory VolumeHumansLogistic ModelsMalePseudomonas aeruginosaPseudomonas InfectionsRetrospective StudiesAnti-Bacterial AgentsAzithromycinColistincolistinmethanesulfonic acidTobramycinazithromycincystic fibrosislung functionpulmonary exacerbationtobramycin

Identifiers

PMID30840835
PMCPMC6600836
OpenAlexW2921684183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.